H.R. 379 (119th)Bill Overview

Healthcare Freedom and Choice Act

Health|Administrative law and regulatory proceduresDepartment of Health and Human Services
Cosponsors
Support
Republican
Introduced
Jan 14, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by t…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill, titled the Healthcare Freedom and Choice Act, declares that the interagency final rule published at 89 Fed. Reg. 23338 (April 3, 2024) by the IRS, Employee Benefits Security Administration, and HHS concerning short-term limited-duration insurance and independent, noncoordinated excepted benefits coverage shall have no force or effect.

Why people may split

Choice and affordability versus comprehensive consumer protections

Watch point

Relative to its intended legislative type, this bill is narrowly and unambiguously drafted to eliminate a single named final interagency rule, but it provides little accompanying detail on implementation, interaction with existing law, fiscal impact, transitions, or oversight.

The bill, titled the Healthcare Freedom and Choice Act, declares that the interagency final rule published at 89 Fed.

Reg. 23338 (April 3, 2024) by the IRS, Employee Benefits Security Administration, and HHS concerning short-term limited-duration insurance and independent, noncoordinated excepted benefits coverage shall have no force or effect.

In short, it nullifies that specific April 3, 2024 regulatory rule.

Passage40/100

Narrow deregulatory intent aids passage in a sympathetic chamber, but contested subject matter and higher Senate thresholds reduce overall odds.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is narrowly and unambiguously drafted to eliminate a single named final interagency rule, but it provides little accompanying detail on implementation, interaction with existing law, fiscal impact, transitions, or oversight.

Contention72/100

Choice and affordability versus comprehensive consumer protections

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Consumers · Federal agenciesConsumers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • ConsumersSupporters may cite increased availability of lower‑cost short‑term insurance plan options for some consumers.
  • Federal agenciesIt would reduce federal regulatory requirements on insurers offering short‑term and excepted benefit products.
  • Potential benefitInsurers and brokers could face fewer compliance burdens, possibly lowering administrative costs.
Likely burdened
  • ConsumersCritics may argue it weakens consumer protections by allowing more limited plans that exclude comprehensive benefits.
  • Potential burdenIt could increase risk of adverse selection, raising premiums in ACA‑compliant individual markets.
  • ConsumersMore consumers could face coverage gaps or unexpected out‑of‑pocket costs due to limited plan benefits.
03 · Why people split

Why the argument around this bill splits.

Choice and affordability versus comprehensive consumer protections
Progressive10%

Likely opposed.

They would view nullifying the rule as rolling back consumer protections and reopening pathways to non-ACA plans that can exclude benefits.

They expect increased marketplace risk segmentation and harm to people needing comprehensive coverage.

Likely resistant
Centrist50%

Cautious/mixed.

Appreciates consumer choice and temporary affordability, but worried about adverse selection and consumer confusion.

Would favor targeted guardrails and transparency measures rather than wholesale nullification without safeguards.

Split reaction
Conservative85%

Likely supportive.

Views nullification as reducing federal overreach, restoring market choice, and improving short-term affordability.

Prefers state flexibility and private-market solutions over the challenged federal rule.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Narrow deregulatory intent aids passage in a sympathetic chamber, but contested subject matter and higher Senate thresholds reduce overall odds.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No CBO score or quantified market impact included
  • Unknown level of bipartisan support in each chamber
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Choice and affordability versus comprehensive consumer protections

Narrow deregulatory intent aids passage in a sympathetic chamber, but contested subject matter and higher Senate thresholds reduce overall…

Unlocked analysis

Relative to its intended legislative type, this bill is narrowly and unambiguously drafted to eliminate a single named final interagency rule, but it provides little accompanying detail on implementation, interaction wi…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis